QualityStocks would like to highlight Genta, Inc., a publicly traded biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The company is developing tesetaxel, a novel, orally absorbed taxane that is in the same class of drugs as paclitaxel and docetaxel.
In the company's news yesterday,
Genta announced that it has added the first patient to a new randomized trial of tesetaxel as initial chemotherapy for women with advanced or recurrent breast cancer.
The company expects to enroll 220 patients for the 12-month, randomized phase 2b study, which will be conducted across 15 sites in the U.S. and Western Europe.
The participating women will not have previously received chemotherapy for metastatic or recurrent disease, though eligible patients who are HER2-negative may have received adjuvant chemotherapy and hormonal therapy.
The study will compare two oral chemotherapy agents; patients will be randomized to one of three treatment groups administered twice per day for 14 consecutive days. The primary endpoint of the trial is overall response rate; secondary endpoints include progression-free survival and safety.
In the previously conducted two phase 2a studies, tesetaxel was generally well-tolerated. In the first study, 13 of 34 patients (38 percent) achieved a major objective response, and 11 patients achieved stable disease, for a disease control rate of 70 percent. In the second trial, 20 of 44 patients (45 percent) achieved major objective responses with a disease-control rate of 82 percent.
"Our preliminary results suggest that tesetaxel may compare favorably with capecitabine across a number of parameters, including response, safety, convenience, and compliance," Dr. Loretta M. Itri, Genta's president and chief medical officer stated in the press release. "Genta has now completed two, non-randomized, phase 2a studies comprised of more than 80 patients. The Company has been engaged in extended discussions with regulatory authorities in the U.S. and EU regarding potential registration strategies for tesetaxel in breast cancer. We believe this new study will provide a firm basis for a phase 3 trial design as first-line chemotherapy in this patient population."
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit http://www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read full disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
Read the full story at http://www.prweb.com/releases/2012/6/prweb9565395.htm
|05:02 PM||A 12-Year-Old's Unique Hit App Solves Fraction Problem|
|05:01 PM||Online Insurance Marketplace Explains How Senior Citizens can cover their Funeral and Burial Costs|
|04:03 PM||There is Life After Stroke, Says Book by Jeff Kagan|
|04:03 PM||Genetec AutoVu Simplifies Pay-by-Plate Systems Integration|
|03:17 PM||Paul McCartney Tickets: TicketProcess Adds Additional Tickets For The Paul McCartney 2013 Tour|
|03:03 PM||Torrance Moving Company provides useful information about planning a summer move!|
|03:03 PM||HomeThangs.com Introduces A Guide To Choosing A Professional Quality Range Hood|
|03:02 PM||Texas Adds More Jobs Than Any Other State in Country, EmploymentCrossing Finds 185,000 Jobs in State|
|03:01 PM||Zamansky & Associates LLC Announces Its Investigation of Financial Advisor John Pritchard of Raymond James Morgan Keegan And Oppenheimer|
|02:15 PM||Los Angeles Lakers NBA Apparel & Accessories on sale at SportsFanPlayground.com|
|02:02 PM||Body Firming - The Hottest Treatments Available|
|01:27 PM||New Earrings in Natural Stones and Bright Summer Colors Arriving at Aypearl.com|
|01:01 PM||28 Day Fat Loss Formula Offered To Minnesota Residents|
|01:00 PM||Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC|
|12:36 PM||Editions TV Announces May Air Dates for Omaha, Nebraska|
|12:34 PM||J.J. Taylor Distributing Florida, Inc. Teams Up with Speaker Weatherford and Scholarship Program to Encourage Seffner Students to "Go Green"|
|12:32 PM||Personal Hygiene Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research|
|12:08 PM||Lucintel Profiles Top Five Global Automotive Sensor Companies: Ensuring Economies of Scale Would Drive Industry Growth|
|12:04 PM||BAAB Teaches Startups How to Write Sexy Business Plans that Attract the Right Deal|
|12:04 PM||Audio-Digest Foundation Announces the Release of General Surgery Volume 60, Issue 06: Update on Trauma.|
|12:04 PM||Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy|
|12:03 PM||Buy Justin Timberlake Tickets at TicketTweet.com for great seats to all shows, including tickets to sold out shows.|
|12:03 PM||Power Communication: Secrets of the Alpha Male Book 2 - Available in Apple's iBook Format|
|12:03 PM||Zane Benefits Publishes New Information on Small Business Health Insurance|
|12:03 PM||EXO Foundation Launches New and Improved Website|
|12:02 PM||Domestic Airlines in Australia Industry Market Research Report Now Updated by IBISWorld|
|11:31 AM||'Goodnight Argent,' a Top 40's Pop Rock Band, Battles for Winning Musical Artist Title in "Stadium of Fire Tournament' Hosted by Gigg.com|
|11:31 AM||Global Big Data Market: Industry Trends, Size, Share, Strategic Analysis, Growth and Forecast to 2015 Report Available at ResearchMoz.us|
|11:01 AM||New Dealership Website for Crystal EZ Pay Autos Sales Built by Carsforsale.com(R)|
|11:01 AM||Reagan's Toy Chest Expands Organic Toys For Toddlers Handmade In The USA|
|More Press Releases From PRWeb|